The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Related Posts
Morgan Stanley’s profit beats estimates on record trading revenue, dealmaking boost
By Utkarsh Shetti and Tatiana Bautzer April 15 (Reuters) – Morgan Stanley beat Wall Street expectations for first-quarter profit on…
Meta to raise Quest VR headset prices in US on rising component costs
April 16 (Reuters) – Meta Platforms said on Thursday it would increase the prices of its virtual reality headsets from…
Alaska Airlines orders 110 Boeing planes for expansion plan
By David Shepardson WASHINGTON, Jan 7 (Reuters) – Alaska Airlines is ordering 110 new Boeing planes, the largest single order…